VP of Data Intelligence at Pivotal bioVenture Partners China. His work sits at the intersection of biopharma investing and artificial intelligence. He builds the internal AI pipelines and agent workflows that support the investment team end to end — from deal sourcing and triage through due diligence and portfolio management — and is active in AI-enabled drug discovery and AI4S as both a researcher and an investor. Before joining Pivotal, he led competitive intelligence and business development analysis at a biotech startup, and earlier served as a Senior Knowledge Consultant at McKinsey & Company, where he worked within the firm's China healthcare practice and its global R&D knowledge service line. He holds a PhD in Developmental Genetics and Bioinformatics from New York University, and follows disruptive innovation across the life sciences closely.